FORA Capital LLC Takes $1.03 Million Position in Haleon plc (NYSE:HLN)

FORA Capital LLC acquired a new position in shares of Haleon plc (NYSE:HLN - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 96,992 shares of the company's stock, valued at approximately $1,026,000.

A number of other large investors have also modified their holdings of the stock. AE Wealth Management LLC increased its holdings in Haleon by 6.1% in the second quarter. AE Wealth Management LLC now owns 19,199 shares of the company's stock valued at $159,000 after buying an additional 1,098 shares during the last quarter. Cardinal Capital Management boosted its holdings in Haleon by 2.5% in the 2nd quarter. Cardinal Capital Management now owns 46,231 shares of the company's stock valued at $382,000 after purchasing an additional 1,140 shares in the last quarter. Lake Street Advisors Group LLC boosted its holdings in Haleon by 5.4% in the 3rd quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company's stock valued at $237,000 after purchasing an additional 1,143 shares in the last quarter. Endowment Wealth Management Inc. boosted its stake in shares of Haleon by 9.9% during the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock worth $106,000 after acquiring an additional 1,161 shares in the last quarter. Finally, Portside Wealth Group LLC raised its position in shares of Haleon by 2.7% during the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock worth $372,000 after purchasing an additional 1,182 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Analyst Upgrades and Downgrades

HLN has been the subject of several analyst reports. The Goldman Sachs Group downgraded Haleon from a "buy" rating to a "neutral" rating in a report on Tuesday, August 6th. Berenberg Bank began coverage on Haleon in a report on Tuesday, August 6th. They set a "buy" rating for the company. UBS Group upgraded Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Finally, Morgan Stanley upped their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a research report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Haleon currently has an average rating of "Buy" and a consensus target price of $10.95.

Haleon Stock Down 0.7 %

NYSE:HLN traded down $0.07 on Friday, reaching $9.66. The stock had a trading volume of 2,989,940 shares, compared to its average volume of 5,304,791. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average of $9.94 and a 200 day moving average of $9.41. The stock has a market cap of $43.71 billion, a P/E ratio of 28.59, a price-to-earnings-growth ratio of 2.94 and a beta of 0.30. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.